ATP11B and pancreatic neoplasm: The results showed that the high ATP11B expression was associated with a poor prognosis in both groups, since the survival rate was significantly decreased in CD8 +T cell-rich patients with high ATP11B expression, suggesting that the influence of ATP11B on pancreatic cancer prognosis largely depended on T cell priming (figure 5A, B).